77 related articles for article (PubMed ID: 19099820)
1. [Preliminary investigation on screening for serum protein markers by protein microchips technology in childhood acute lymphocytic leukemia].
Ge YP; Liu WJ; Chen HY
Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):552-3. PubMed ID: 19099820
[No Abstract] [Full Text] [Related]
2. [Serum levels of insulin-like growth factor-1 and growth factor binding protein-3 in children with acute lymphocytic leukemia].
Zhao DJ; Zhang WL; Shi TX
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Feb; 13(2):101-3. PubMed ID: 21342615
[TBL] [Abstract][Full Text] [Related]
3. Analysis of gamma globin chain composition in childhood acute lymphocytic leukemia (ALL).
Iolascon A; Pinto L; Di Tullio MT; Cutillo S
Haematologica; 1988; 73(6):445-8. PubMed ID: 3148505
[No Abstract] [Full Text] [Related]
4. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.
Hagag AA; Abdel-Lateef AE; Aly R
J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921
[TBL] [Abstract][Full Text] [Related]
5. Palmar dermatoglyphics in children with acute lymphoblastic leukemia--a preliminary investigation.
Bukelo MJ; Kanchan T; Rau AT; Unnikrishnan B; Bukelo MF; Krishna VN
J Forensic Leg Med; 2011 Apr; 18(3):115-8. PubMed ID: 21420648
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
[TBL] [Abstract][Full Text] [Related]
7. Early morbidity and mortality in childhood acute lymphoblastic leukemia with very high white blood cell count.
Vaitkeviciene G; Heyman M; Jonsson OG; Lausen B; Harila-Saari A; Stenmarker M; Taskinen M; Zvirblis T; Åsberg A; Groth-Pedersen L; Rageliene L; Schmiegelow K
Leukemia; 2013 Nov; 27(11):2259-62. PubMed ID: 23689480
[No Abstract] [Full Text] [Related]
8. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
[TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia.
Hatzipantelis ES; Athanassiou-Metaxa M; Gombakis N; Tzimouli V; Taparkou A; Sidi-Fragandrea V; Garipidou V; Papageorgiou T; Kleta D; Koliouskas DE; Athanasiadou-Piperopoulou F
Acta Haematol; 2011; 125(3):130-5. PubMed ID: 21150180
[TBL] [Abstract][Full Text] [Related]
10. High white cell count at presentation in children with acute lymphoblastic leukaemia.
Menon BS; Wan Maziah WM; Jackson N; Jamaluddin N; Narazah MY; Dasgupta A; Naing NN
Med J Malaysia; 1999 Jun; 54(2):283-4. PubMed ID: 10972046
[No Abstract] [Full Text] [Related]
11. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute lymphoblastic leukemia using biochip array technology.
Horacek JM; Kupsa T; Vasatova M; Jebavy L; Zak P
Exp Oncol; 2013 Sep; 35(3):229-30. PubMed ID: 24084464
[TBL] [Abstract][Full Text] [Related]
13. Distribution of ABO blood groups in childhood acute leukemia.
Alavi S; Ashraf H; Rashidi A; Hosseini N; Abouzari M; Naderifar M
Pediatr Hematol Oncol; 2006 Dec; 23(8):611-7. PubMed ID: 17065136
[TBL] [Abstract][Full Text] [Related]
14. Increased neonatal level of arginase 2 in cases of childhood acute lymphoblastic leukemia implicates immunosuppression in the etiology.
Nielsen AB; Zhou M; de Smith AJ; Wang R; McCoy L; Hansen H; Morimoto L; Grønbæk K; Johansen C; Kogan SC; Metayer C; Bracci PM; Ma X; Wiemels JL
Haematologica; 2019 Nov; 104(11):e514-e516. PubMed ID: 30923090
[No Abstract] [Full Text] [Related]
15. Are elevated serum levels of IGFBP-2 after intensive chemotherapy of childhood acute lymphoblastic leukemia a risk factor of relapse?
Kitszel A; Krawczuk-Rybak M
Adv Med Sci; 2007; 52():147-53. PubMed ID: 18217408
[TBL] [Abstract][Full Text] [Related]
16. Markers of apoptosis and proliferation related gene products as predictors of treatment outcome in childhood acute lymphoblastic leukemia.
Hafez M; Al-Tonbary Y; El-Bayoumi MA; Hatem N; Hawas S; Mansour A; Marzouk I; Hafez MM; Yahia S; Farahat N
Hematology; 2007 Jun; 12(3):209-18. PubMed ID: 17558696
[TBL] [Abstract][Full Text] [Related]
17. Altered erythrocyte membrane characteristics during anemia in childhood acute lymphoblastic leukemia.
Ghosh S; Bandyopadhyay S; Bhattacharya DK; Mandal C
Ann Hematol; 2005 Feb; 84(2):76-84. PubMed ID: 15338196
[TBL] [Abstract][Full Text] [Related]
18. [Expression and role of cyclin D3 in childhood acute leukemia].
Zhang L; Li J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):347-9. PubMed ID: 11721429
[TBL] [Abstract][Full Text] [Related]
19. Acute leukemia in children.
Choudhry VP; Arya LS; Marwaha RK; Pati H; Saraya AK
Indian Pediatr; 1988 Aug; 25(8):734-9. PubMed ID: 3220559
[No Abstract] [Full Text] [Related]
20. Platelet aggregation in children with acute lymphoblastic leukemia during induction of remission therapy.
Jaime-Pérez JC; Cantú-Rodríguez OG; Herrera-Garza JL; Gómez-Almaguer D
Arch Med Res; 2004; 35(2):141-4. PubMed ID: 15010194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
